Show simple item record

dc.contributor.authorTaylor-Rowan, Martin
dc.contributor.authorEdwards, Sophie
dc.contributor.authorNoel-Storr, Anna H
dc.contributor.authorMcCleery, Jenny
dc.contributor.authorMyint, Phyo K
dc.contributor.authorSoiza, Roy
dc.contributor.authorStewart, Carrie
dc.contributor.authorLoke, Yoon Kong
dc.contributor.authorQuinn, Terry J
dc.date.accessioned2022-05-04T23:04:47Z
dc.date.available2022-05-04T23:04:47Z
dc.date.issued2021-05-05
dc.identifier.citationTaylor-Rowan , M , Edwards , S , Noel-Storr , A H , McCleery , J , Myint , P K , Soiza , R , Stewart , C , Loke , Y K & Quinn , T J 2021 , ' Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome (Review) ' , Cochrane Database of Systematic Reviews , vol. 5 , no. 4 , CD013540 . https://doi.org/10.1002/14651858.CD013540.pub2en
dc.identifier.issn1469-493X
dc.identifier.otherPURE: 192703917
dc.identifier.otherPURE UUID: 833f1ffd-a1b7-4d4b-91c9-7e9ce1af8d71
dc.identifier.otherORCID: /0000-0002-1397-4272/work/93483007
dc.identifier.otherPubMed: 34097766
dc.identifier.otherScopus: 85105467209
dc.identifier.urihttps://hdl.handle.net/2164/18521
dc.descriptionFunding Information: National Institute on Aging, NIH Grants, and the Branta Foundation Funding Information: We followed best practice in design, conduct, and reporting of our prognosis review as detailed in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2019). The review was supported by the Cochrane Prognostic Methods Group, partners within the Cochrane Mental Health and Neuroscience Network, and the UK National Institute for Health Research Complex Reviews Support Unit (NIHR CRSU). Funding Information: American Philosophical Society, the National Institute on Aging grants, and by the Illinois Department of Public Health to DAB Funding Information: This protocol was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Dementia and Cognitive Improvement group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service or the Department of Health Publisher Copyright: Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.en
dc.format.extent71
dc.language.isoeng
dc.relation.ispartofCochrane Database of Systematic Reviewsen
dc.rightsThis Protocol of a Cochrane Review was published in the Cochrane Database of Systematic Reviews 2021, Issue 4. Cochrane Protocols and Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Protocol.en
dc.subjectR Medicineen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleAnticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome (Review)en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1002/14651858.CD013540.pub2
dc.date.embargoedUntil2022-05-05
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85105467209&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record